je.st
news
Tag: clinical
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
2013-11-04 12:23:21| Biotech - Topix.net
Active Biotech announced today that its partner Teva Pharmaceutical Industries Ltd. will initiate a further clinical trial, LIBRETTO, to evaluate the efficacy, safety and tolerability of two doses of oral laquinimod , compared to interferon beta-1a, in patients with relapsing remitting multiple sclerosis.
Tags: partner
active
multiple
trial
Clinical Chemistry Reagents last up to 2 years.
2013-10-18 14:30:14| Industrial Newsroom - All News for Today
Manufactured in ISO9001-certified production facility, Clinical Chemistry Reagents load directly onto Diatron Pictus clinical chemistry analyzers, enabling automatic reruns and reflex testing. Protein assays demonstrate low interference from hook effect or heterophilic antibodies, while Ab-latex binding technique optimizes quality in immunoturbidimetric-based assays. Barcoded for traceability, CE marked tests include substrates, enzymes, electrolytes, lipids, specific proteins, and special tests. This story is related to the following:Reagents |
Tags: to
years
clinical
chemistry
Clinical Review Displays allow review of X-ray images anytime.
2013-10-15 14:31:31| Industrial Newsroom - All News for Today
Utilizing LED technology, Clinical Review Displays are available in 24 in. screen size with IPS panel, and 27 in. size with AMVA panel. Clinical D-image function, when activated, enables monitors to deliver DICOM part 14 compatible, grayscale standard display performance. Optimized pixel management technologies provide 178/178° extra-wide viewing angle, resulting in crisp images even in 90° pivot mode. Additional features include anti-microbial additive in housing and medical-grade power supply. This story is related to the following:Electrical Equipment and Systems Sponsored by: Globtek Inc. - MOBILE BANNER ADMedical Imaging Displays |
Tags: review
images
clinical
displays
Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology
2013-10-14 23:02:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind. Merck and Endocytes Phase III PROCEED pivotal trial of vintafolide in ovarian cancer ongoing WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology. Language: English Contact: MerckMedia:Caroline Lappetito,267-305-7639Caroline.Lappetito@Merck.comorClaire Mulhearn, 908-423-7425Claire.Mulhearn@Merck.comorInvestors:Carol Ferguson, 908-423-4465Carol.Ferguson@Merck.comorJustin Holko, 908-423-5088Justin_Holko@Merck.comorEndocyteMedia:Tony Russo, 212-845-4251Tony.Russo@Russopartnersllc.comorMartina Schwarzkopf, 212-845-4292Martina.Schwarzkopf@Russopartnersllc.comorInvestors:Stephanie Ascher, 212-362-1200Stephanie@sternir.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more
Tags: of
results
journal
published
Pfizer psoriasis drug succeeds in clinical trials
2013-10-10 13:10:46| Biotech - Topix.net
Pfizer Inc. reported Wednesday that two late-stage clinical trials of its experimental treatment for a chronic psoriasis condition proved successful.
Tags: drug
clinical
trials
succeeds
Sites : [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] next »